Study Bolsters Evidence that Effects of Puberty Blockers Are Reversible

Medications commonly known as puberty blockers were found to delay development of female reproductive organs but allow for restoration of reproductive functioning after the medications were withdrawn, according to a new study being presented this week at the American Physiology Summit.

Longer treatment with puberty-delaying medication in transgender youth leads to lower bone mineral density

A longer duration of treatment with puberty-delaying medications among transgender youth is associated with lower bone mineral density, according to a new study that will be presented Sunday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.

Endocrine Society opposes Florida Department of Health policy on gender dysphoria treatment for children and adolescents

The Endocrine Society objects to the Florida Department of Health’s bulletin on gender-affirming care for transgender and gender-diverse youth. The bulletin contradicts the U.S. Department of Health & Human Services’ resources and the Society’s own evidence-based Clinical Practice Guideline regarding gender-affirming care.